3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer

Medical Oncology

Volumn 31, Issue 5, 2014, Pages

  Omrane, Inés ^a   Mezlini, Amel ^b   Baroudi, Olfa ^a   Stambouli, Nejla ^a   Bougatef, Karim ^a   Ayari, Hager ^a   Medimegh, Imen ^a   Bouzaienne, Hassen ^a   Uhrhammer, Nancy ^c   Bignon, Yves Jean ^c   Benammar Elgaaied, Amel ^a   Marrakchi, Raja ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b SALAH AZAIEZ INSTITUTE   (Tunisia)

^c CENTRE JEAN PERRIN   (France)

Author keywords

Association; Chemotherapy; Colorectal cancer; Crohn's disease; NOD2 CARD15 3020insC; Treatment

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15;

ADULT; ALLELE; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUTANT; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS;

EID: 84897367373     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0954-z     Document Type: Article

References (26)

1. Bougatef K, Marrakchi R, Ouerhani S, Sassi R, Moussa A, Kourda N, et al. No evidence of the APC D1822V missense variant's pathogenicity in Tunisian patients with sporadic colorectal cancer. Pathol Biol. 2009;57(3):e67-71.
2. Deschoolmeester V, Baay M, Lardon F, Pauwels P, Peeters M. Immune cells in colorectal cancer: prognostic relevance and role of MSI. Cancer Microenviron. 2011;4(3):377-92.
3. Mustapha MA, Shahpudin SN, Aziz AA, Ankathil R. Risk modification of colorectal cancer susceptibility by interleukin-8 -251T>A polymorphism in Malaysians. World J Gastroenterol. 2012;18(21):2668-73.
4. Mantovani A. Cancer: inflammation by remote control. Nature. 2005;435(7043):752-3. (Pubitemid 40839716)
5. Angeletti S, Galluzzo S, Santini D, Ruzzo A, Vincenzi B, Ferraro E, et al. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol. 2009;70(9):729-32.
6. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117(5):1175-83. (Pubitemid 46718402)
7. Kutikhin AG. Role of NOD1/CARD4 and NOD2/CARD15 gene polymorphisms in cancer etiology. Hum Immunol. 2011;72(10):955-68.
8. Kurzawski G, Suchy J, Kladny J, Grabowska E, Mierzejewski M, Jakubowska A, et al. The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res. 2004;64(5):1604-6. (Pubitemid 38428679)
9. Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Osterreicher C, Tulassay Z, et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: pheno-type-genotype correlations. World J Gastroenterol. 2005;11(10): 1489-95. (Pubitemid 40468084)
10. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603-6. (Pubitemid 32531409)
11. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411(6837):599-603. (Pubitemid 32531408)
12. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70(4):845-57. (Pubitemid 34259301)
13. Papaconstantinou I, Theodoropoulos G, Gazouli M, Panoussopoulos D, Mantzaris GJ, Felekouras E, et al. Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer. 2005;114(3):433-5. (Pubitemid 40279965)
14. Tian Y, Li Y, Hu Z, Wang D, Sun X, Ren C. Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis. Int J Colorectal Dis. 2010;25(2):161-8.
15. Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, Lakatos L, et al. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer. 2007;7:54.
16. Marrakchi R, Bougatef K, Moussa A, Ouerhani S, Khodjet-el-Khil H, Messai Y, et al. 3020insC insertion in NOD2/CARD15 gene, a prevalent variant associated with anti-Saccharomyces cerevisiae antibodies and ileal location of Crohn's disease in Tunisian population. Inflamm Res. 2009;58(4):218-23.
17. Alhopuro P, Ahvenainen T, Mecklin JP, Juhola M, Jarvinen HJ, Karhu A, et al. NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res. 2004;64(20):7245-7. (Pubitemid 39372060)
18. Mockelmann N, von Schonfels W, Buch S, von Kampen O, Sipos B, Egberts JH, et al. Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC gastroenterol. 2009;9:79.
19. Suchy J, Klujszo-Grabowska E, Kladny J, Cybulski C, Wokolorczyk D, Szymanska-Pasternak J, et al. Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer. 2008;8:112.
20. Roberts RL, Gearry RB, Allington MD, Morrin HR, Robinson BA, Frizelle FA. Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res. 2006;66(5):2532-5.
21. Szeliga J, Sondka Z, Jackowski M, Jarkiewicz-Tretyn J, Tretyn A, Malenczyk M. NOD2/CARD15 polymorphism in patients with rectal cancer. Med Sci Monit. 2008;14(9):CR480-4.
22. Barreiro M, Nunez C, Dominguez-Munoz JE, Lorenzo A, Barreiro F, Potel J, et al. Association of NOD2/CARD15 mutations with previous surgical procedures in Crohn's disease. Rev Esp Enferm Dig. 2005;97(8):547-53. (Pubitemid 43803692)
23. Alvarez-Lobos M, Arostegui JI, Sans M, Tassies D, Plaza S, Delgado S, et al. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg. 2005;242(5):693-700. (Pubitemid 41567125)
24. Buning C, Genschel J, Buhner S, Kruger S, Kling K, Dignass A, et al. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther. 2004;19(10):1073-8. (Pubitemid 38703519)
25. Laghi L, Costa S, Saibeni S, Bianchi P, Omodei P, Carrara A, et al. Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn's ileal disease. Aliment Pharmacol Ther. 2005;22(6):557-64. (Pubitemid 41360802)
26. Russell RK, Drummond HE, Nimmo EE, Anderson N, Smith L, Wilson DC, et al. Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflamm Bowel Dis. 2005;11(11):955-64. (Pubitemid 41580008)